The FREND System is a quantitative immunoassay analyzing instrument that utilizes disposable cartridges to provide in vitro diagnostic results.
The FREND COVID-19 total Ab is a fluorescence immunoassay (FIA) which can be used to aid in identifying individuals with an adaptive immune response to SARS-CoV-2 using human plasma. It shows qualitative results by using SARS-CoV-2 Nucleocapsid fluorescent beads to detect total antibody (IgG and IgM).
This system provides lab-quality immunoassay testing for PSA, Free T4, Testosterone, TSH and Vitamin D in just a few minutes.
Rapid diagnosis at the point of care site increases efficiency and patient satisfaction.
This compact, benchtop unit saves space, is easy to use, delivers results within minutes, and requires no user calibration.